Will the Placebo Effect Disappear With New Targets For Treatment of Inflammatory Bowel Diseases?

Affiliations

• ¹ Department of Gastroenterology and Inserm NGERE, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, Nancy, France; Department of Hepato-Gastroenterology, University Hospital of Grenoble, University of Grenoble Alpes, Grenoble, France.
• ² Department of Gastroenterology and Inserm NGERE, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, Nancy, France; Institut des Maladies de l'Appareil Digestif, Nantes University Hospital, Nantes, France.
• ³ Department of Gastroenterology and Inserm NGERE, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, Nancy, France.